Four clinically utilized drugs were identified and validated for treatment of adrenocortical cancer using quantitative high-throughput screening
<p>Abstract</p> <p>Background</p> <p>Drug repurposing for cancer treatment is an emerging approach to discover clinically approved drugs that demonstrate antineoplastic effect. The effective therapeutics for patients with advanced adrenocortical carcinoma(ACC) are great...
Main Authors: | Nilubol Naris, Zhang Lisa, Shen Min, Zhang Ya-Qin, He Mei, Austin Christopher P, Kebebew Electron |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-09-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | http://www.translational-medicine.com/content/10/1/198 |
Similar Items
-
Current Status and Future Targeted Therapy in Adrenocortical Cancer
by: George Alyateem, et al.
Published: (2021-03-01) -
Adrenocortical Carcinoma
by: Alfredo Berruti, et al.
Published: (2021-03-01) -
Angiogenesis in the Normal Adrenal Fetal Cortex and Adrenocortical Tumors
by: Sofia S. Pereira, et al.
Published: (2021-03-01) -
Astemizole Sensitizes Adrenocortical Carcinoma Cells to Doxorubicin by Inhibiting Patched Drug Efflux Activity
by: Anida Hasanovic, et al.
Published: (2020-07-01) -
Progress in Anti-Mammarenavirus Drug Development
by: Yu-Jin Kim, et al.
Published: (2021-06-01)